These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 32587771)
1. Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer. Li Y; Xin J; Sun Y; Han T; Zhang H; An F Cancer Biol Med; 2020 May; 17(2):307-327. PubMed ID: 32587771 [TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Zhu L; Zhou Z; Mao H; Yang L Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448 [TBL] [Abstract][Full Text] [Related]
3. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics. Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998 [TBL] [Abstract][Full Text] [Related]
4. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery. El-Boubbou K Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817 [TBL] [Abstract][Full Text] [Related]
5. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. El-Boubbou K Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469 [TBL] [Abstract][Full Text] [Related]
6. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices. Hajba L; Guttman A Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617 [TBL] [Abstract][Full Text] [Related]
7. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy. Hu Y; Mignani S; Majoral JP; Shen M; Shi X Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542 [TBL] [Abstract][Full Text] [Related]
8. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy. Du Y; Liu X; Liang Q; Liang XJ; Tian J Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627 [TBL] [Abstract][Full Text] [Related]
9. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412 [TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticles for cancer theranostics: Advances and prospects. Li X; Li W; Wang M; Liao Z J Control Release; 2021 Jul; 335():437-448. PubMed ID: 34081996 [TBL] [Abstract][Full Text] [Related]
11. Fe Li Y; Zhang H Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317 [TBL] [Abstract][Full Text] [Related]
12. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627 [TBL] [Abstract][Full Text] [Related]
13. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics? Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009 [TBL] [Abstract][Full Text] [Related]
14. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics. Luo Y; Tang Y; Liu T; Chen Q; Zhou X; Wang N; Ma M; Cheng Y; Chen H Chem Commun (Camb); 2019 Feb; 55(13):1963-1966. PubMed ID: 30681672 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T Shen Z; Chen T; Ma X; Ren W; Zhou Z; Zhu G; Zhang A; Liu Y; Song J; Li Z; Ruan H; Fan W; Lin L; Munasinghe J; Chen X; Wu A ACS Nano; 2017 Nov; 11(11):10992-11004. PubMed ID: 29039917 [TBL] [Abstract][Full Text] [Related]
16. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine. Vallabani NVS; Singh S; Karakoti AS Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. Kandasamy G; Maity D Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409 [TBL] [Abstract][Full Text] [Related]
18. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics. Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014 [TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme. Yao J; Hsu CH; Li Z; Kim TS; Hwang LP; Lin YC; Lin YY Curr Pharm Des; 2015; 21(36):5256-66. PubMed ID: 26412354 [TBL] [Abstract][Full Text] [Related]
20. A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis. Sharma S; Bhattacharya S; Joshi K; Singh S J Cancer Res Clin Oncol; 2023 Nov; 149(17):16157-16177. PubMed ID: 37650995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]